https://journalzone.org/index.php/bjgesd/issue/feedBritish Journal of Global Ecology and Sustainable Development2024-12-07T12:57:00+00:00Open Journal Systems<p style="text-align: justify;"><strong><span style="font-size: 10.5pt;">British Journal of Global Ecology and Sustainable Development</span></strong><span style="font-size: 10.5pt;"> allows the authors to publish their original research articles in a multidisciplinary field. The British Journal of Global Ecology and Sustainable Development is an open-access, peer-reviewed monthly journal. The journal is refereed and follows the ethics and practices of ethical open-access publishing. All the manuscripts received for publication pass through an extensive double-blind peer review process. The journal covers the multidisciplinary areas of Agriculture and sustainability,</span> <span style="font-size: 10.5pt;">Climate change/ecosystems, Poverty/international development, Energy and sustainable development, Ecological economics, Educational Advancements, Sciences, Humanities, Species, population, community, ecosystem, and biome. Authors can submit their original manuscripts for peer review.</span></p> <p style="background: white;"><strong><span style="font-size: 10.5pt;">Frequency of Publication:</span></strong><span style="font-size: 10.5pt;"> Monthly</span></p> <p style="background: white;"><span style="font-size: 10.5pt;"><strong>Accepted Language:</strong> English</span></p> <p style="background: white; box-sizing: border-box; line-height: 1.785rem; margin: 0.714rem 0px; color: rgba(0, 0, 0, 0.87); font-variant-ligatures: normal; font-variant-caps: normal; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; word-spacing: 0px;"><strong style="box-sizing: border-box;"><span style="font-size: 10.5pt;">The period from submission to acceptance notification is:</span></strong><span style="font-size: 10.5pt;"> 12 Weeks </span></p> <p style="background: white; box-sizing: border-box; line-height: 1.785rem; margin: 0.714rem 0px; color: rgba(0, 0, 0, 0.87); font-variant-ligatures: normal; font-variant-caps: normal; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; word-spacing: 0px;"><span style="font-size: 10.5pt;"><strong>ISSN (E):</strong> 2754-9291</span></p> <p style="background: white; box-sizing: border-box; line-height: 1.785rem; margin: 0.714rem 0px; color: rgba(0, 0, 0, 0.87); font-variant-ligatures: normal; font-variant-caps: normal; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; word-spacing: 0px;"><a href="http://ifsij.com/jif-rank"><span style="font-size: 10.5pt;"><strong>Journal Impact Factor:</strong> 9.025</span></a></p> <p style="background: white; box-sizing: border-box; line-height: 1.785rem; margin: 0.714rem 0px; color: rgba(0, 0, 0, 0.87); font-variant-ligatures: normal; font-variant-caps: normal; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; word-spacing: 0px;"><a href="http://sjifactor.com/passport.php?id=22081"><span style="font-size: 10.5pt;"><strong>SJIF 2024: </strong>7.541</span></a></p>https://journalzone.org/index.php/bjgesd/article/view/658A NOVEL APPROACH TO CERULOPLASMIN STABILITY: PUTTING PROTEASE INHIBITORS INTO PRACTICE2024-12-07T12:57:00+00:00Polyarush Svetlana Vitalievnairoda_2727@mail.ruRyskulov Farrukhiroda_2727@mail.ruMasaidova Iroda Bаkhtier kiziiroda_2727@mail.ru<p>Ceruloplasmin (CP) is a multi-subunit protein that is central to copper metabolism in the human body [7; Р. 722–732]. This protein not only performs a transport function by delivering copper to tissues, but also serves as an important marker of inflammatory processes and pathologies associated with impaired copper metabolism [3; Р. 6904–6910, 8; Р. 27–36]. Additional studies have shown that plasma ceruloplasmin levels can be altered in a variety of diseases, including hereditary and autoimmune disorders [5; Р. 887–905]. This emphasises the critical importance of accurate quantification of its levels in clinical practice, as these data can have a significant impact on diagnosis and subsequent treatment [1; Р. 1–18].</p>2024-12-07T00:00:00+00:00Copyright (c) 2024